Impact of a Biophoton Therapy on Patients With Brain Disorders
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 4 weeks
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "The participant will live in the hotel-like research center for 4 weeks, or 6 weeks if the participants are randomly placed in a placebo group."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. About 80 patients with brain disorder (Alzheimer's disease, dementia, stroke, traumatic brain injury, Parkinson's disease) will participate in the intervention clinical study at the Tesla MedBed Center located in Butler, PA.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * Must meet conditions for approval. * Must be 18-years or older and stay in a hotel. * Must have a caregiver willing to support the participant's full involvement in the study. • The caregiver can assist in completing all study surveys. * Can provide informed consent or can be assisted by caregiver. * Can provide a clinical diagnosis of a brain disorder. * Can complete all study procedures during the study. * Must be fluent in English (or the Caregiver can fully translate). * Women of childbearing age must provide results of a pregnancy test in order to participate. Exclusion Criteria: * Any untreated mental illnesses, that would affect study participation. This will be judged by the caregiver, or by the clinical study medical expert. * Someone that relies on a ventilator. * Someone who has a deep brain stimulator, pacemaker, or any implanted electronic devices. * Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe diabetes, kidney failure, or any end-of-life prognosis. * Is participating in another investigational drug or device trial. * Has an active infectious disease, such as COVID-19. * Pregnant women.
Study sites (1)
PA
- Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001 · Butler, PA 16001Jessica Jackson, PhD Candidate · Study contact · 3029222486 · jessica.jackson@firstallmed.orgAudrey Ager · Study contact · 7248101020 · Audrey.ager@teslabiohealing.comMariola Smotrys, MD, MS, MBA · Principal investigatorLarry Alpert, MD · Sub-investigatorMore trials in Butler